Article

Isotypes may Predict Rheumatoid Arthritis

Measuring for the presence of three rheumatoid factor isotypes may increase the chance of serologically diagnosing rheumatoid arthritis, according to a study published in the Journal of Rheumatology.

Measuring for the presence of three rheumatoid factor isotypes may increase the chance of serologically diagnosing rheumatoid arthritis, according to a study published in the Journal of Rheumatology.

Researchers from the Associated Regional and University Pathologists Institute for Clinical and Experimental Pathology in Salt Lake City analyzed serum samples from 1,021 general population patients. They examined the value of measuring RF isotypes in relation to IgG anti-cyclic citrullinated peptide (CCP) antibodies in the general population.

The results demonstrated the measuring the three isotypes of RF may increase by seven- to 21-fold the chance of making the serologic diagnosis of RA.

Related Videos
Kimberly A. Davidow, MD: Elucidating Risk of Autoimmune Disease in Childhood Cancer Survivors
Matthew J. Budoff, MD: Examining the Interplay of Coronary Calcium and Osteoporosis | Image Credit: Lundquist Institute
Orrin Troum, MD: Accurately Imaging Gout With DECT Scanning
John Stone, MD, MPH: Continuing Progress With IgG4-Related Disease Research
Philip Conaghan, MBBS, PhD: Investigating NT3 Inhibition for Improving Osteoarthritis
Rheumatologists Recognize the Need to Create Pediatric Enthesitis Scoring Tool
Presence of Diffuse Cutaneous Disease Linked to Worse HRQOL in Systematic Sclerosis
Alexei Grom, MD: Exploring Safer Treatment Options for Refractory Macrophage Activation Syndrome
Jack Arnold, MBBS, clinical research fellow, University of Leeds, Leeds Institute of Rheumatic and Musculoskeletal Medicine
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
© 2024 MJH Life Sciences

All rights reserved.